Digital Ally (DGLY) signed a Master Distribution Agreement with Redwood Scientific Technologies, granting Digital Ally exclusive global rights to distribute Redwood’s clinically-driven nicotine cessation products, including TBX-Free and TBX Vape-Free. This Agreement establishes Digital Ally as the exclusive commercialization partner for a product designed to help Americans overcome addiction to vape devices. TBX Vape-Free, delivered via oral thin-film technology, is expected to be the first product of its kind to directly target vape-related nicotine dependency. This Agreement provides Digital Ally the exclusive global rights to Redwood’s full range of technologies, brands, trademarks, manufacturing processes, vendor relationships, and additional essential assets.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DGLY:
